NCT02312934 2020-01-21
Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study
Vanderbilt University Medical Center
Phase 2 Completed
Clinical Trials
1 trialsInterventional × Chemotherapy-Related Cognitive Impairment × Tobacco Use Cessation Devices × Clear all